Santhera Pharmaceuticals Holding Ltd. header image

Santhera Pharmaceuticals Holding Ltd.

SANN

Equity

ISIN CH1276028821 / Valor 127602882

SIX Swiss Exchange (2026-11-04)
CHF 15.20%

Santhera Pharmaceuticals Holding Ltd.
UMushroom community rating:

star star star star star
5.00 1 votes No rating yet
NegativeNeutralPositive

About company

Santhera Pharmaceuticals Holding Ltd. is a Swiss specialty pharmaceutical company that develops and commercializes therapies for rare neuromuscular, mitochondrial and related pulmonary disorders. Its work has centered on orphan-drug programs — most prominently formulations of idebenone (marketed in some indications) — and clinical development efforts in Duchenne muscular dystrophy and other rare disease indications. The company operates as a typical small-cap biotech, generating revenues from product sales where marketed and from partnerships, milestone and licensing arrangements, while relying on ongoing clinical development, regulatory filings and capital markets financing to advance its pipeline and expand geographic reach.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

44.5%1Y
38.7%3Y
16.0%5Y

Performance

50.3%1Y
54.6%3Y
64.8%5Y

Volatility

Market cap

249 M

Market cap (USD)

Daily traded volume (Shares)

41,575

Daily traded volume (Shares)

1 day high/low

12.7 / 11.56

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

5.00

1 votes
Performance:
starstarstarstarstar
5.00
Innovation:
starstarstarstarstar
5.00
Society:
starstarstarstarstar
5.00
Nature:
starstarstarstarstar
5.00
Luba Schoenig
Switzerland, 20 Mar 2025
star star star star star
Ein top innovatives Unternehmen, das sich auf die Behandlung von DMD spezialisiert und seine Marktstellung kontinuierlich ausbaut

EQUITIES OF THE SAME SECTOR

Alphabet Inc
Alphabet Inc Alphabet Inc Valor: 29798545
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.31%USD 291.08
Schneider Electric SE
Schneider Electric SE Schneider Electric SE Valor: 509120
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.90%EUR 233.63
Wipro Limited
Wipro Limited Wipro Limited Valor: 1006385
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.95%INR 193.75
Zensar Technologies Limited
Zensar Technologies Limited Zensar Technologies Limited Valor: 43200200
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.05%INR 532.95
Data Patterns (India) Limited
Data Patterns (India) Limited Data Patterns (India) Limited Valor: 115413439
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.47%INR 4,082.00
EnerSys Inc
EnerSys Inc EnerSys Inc Valor: 1865089
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-7.12%USD 156.00
ASML Holding NV
ASML Holding NV ASML Holding NV Valor: 19531091
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.42%EUR 1,312.00
Black Box Limited
Black Box Limited Black Box Limited Valor: 118606432
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.23%INR 808.05
Super Micro Computer Inc
Super Micro Computer Inc Super Micro Computer Inc Valor: 138624448
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-9.60%USD 26.76
net digital AG
net digital AG net digital AG Valor: 35045378
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.05%EUR 28.60